Why Did Marvell Technology Stock Drop Today?

Marvell (MRVL) topped expectations in fiscal Q2 2027 with EPS of $0.94 vs $0.93 consensus and revenue of $2.74B vs $2.71B, while reporting GAAP EPS of $0.33 (up 50% YoY) and 37% YoY sales growth. Guidance for fiscal Q3 2027 calls for $3.15B revenue, gross margins ~53.4%, GAAP EPS ~$0.53 and non-GAAP EPS ~$1.10, meeting or exceeding forecasts. Despite the beat, the stock fell ~8% intraday on concerns that valuation remains very expensive at ~84x trailing earnings (PEG well above 1), implying downside risk if growth doesn’t justify the multiple.

Analysis

MRVL is behaving like a duration asset, not a fundamentals story: at this multiple, a clean beat is not enough unless it also de-risks the forward growth slope. The selloff implies the market is telling us that AI infrastructure demand is still being capitalized as “good” rather than “scarce,” so any sign of decelerating order growth, mix shift, or margin plateau will compress the multiple faster than earnings can grow.

Relative winners are the larger, better-moated AI semis and networking names where scale and backlog reduce quarterly disappointment risk: NVDA, AVGO, and to a lesser extent ANET. If capex budgets stay intact but procurement shifts toward vendors with clearer platform control, MRVL can lose share-of-wallet even if the overall spend pie keeps expanding. That creates a second-order headwind for smaller AI suppliers and a relative tailwind for the category leaders.

Near term, the stock is vulnerable over the next 1-3 months because the market will focus less on reported growth and more on whether the next guide implies normalization from a still-elevated base. The main reversal trigger is an upward revision to FY27/AI-related revenue mix or a sharp re-rating in semiconductor multiples driven by falling rates; absent that, the path of least resistance is lower because the valuation embeds little room for execution variance.

Contrarian view: the move may be somewhat overdone if investors are extrapolating a single-quarter valuation reset into a structural demand problem. If free cash flow keeps converting and gross margin holds in the low-50s, MRVL can still grow into the multiple over 12-18 months — but the burden of proof has shifted to management to show that AI custom silicon and interconnect are becoming a durable franchise, not a cyclical spike.

Key Decisions for Investors

• Short MRVL on any post-earnings relief rally over the next 5-10 trading days; use a tight risk stop if the stock recovers the entire post-print gap and holds there for 2 sessions.
• Prefer a relative-value pair: long NVDA or AVGO / short MRVL for 1-3 months, targeting valuation compression in the smaller, less diversified name while keeping broad AI spend exposure.
• If options liquidity is sufficient, buy MRVL put spreads 1-2 months out to express downside from multiple compression; the thesis fails if the company raises AI revenue guide or FCF inflects materially higher next quarter.
• Use SOXX as a hedge against semiconductor beta while isolating idiosyncratic MRVL downside; this is cleaner than an outright sector short if the macro tape remains constructive.
• Watch 10-year yields and semiconductor index multiples: a fast fall in rates could invalidate the short by re-expanding long-duration tech valuations even without any fundamental improvement.